← Leaderboards
Rajesh Singh
Morehouse School Of Medicine
$2,720,240
Attributed
$3,932,443
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $812K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,932,443 · 5
By mechanism
R01$1,738,430 · 1
SC1$1,415,000 · 1
U54$779,013 · 3
Top collaborators
- Brian M. Rivers4 shared
- Shailesh Singh3 shared
Most similar at Morehouse School Of Medicine
Same institution · by research overlap
- Brian M. Rivers$11,848,945
- Clayton Yates$11,417,167
- James W Lillard$4,925,420
- Shailesh Singh$6,393,124
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTumorMorehouse School Of MedicineInnovationCancer TherapyMolecularMalignant Neoplasm Of ProstateNanoparticleTissuesDocetaxelOverexpressionMalignant NeoplasmsAffectCancer Health DisparityIn VivoProstate Cancer CellCharacteristicsDesignCancer PatientMediatingGene Expression ProfilingMortalityDisease OutcomeBase
Grant awards (11)
The interplay of social and molecular determinants in lung cancer disparity$589,299
R01 · FY2025 · CA
The interplay of social and molecular determinants in lung cancer disparity$559,834
R01 · FY2024 · CA
Project 1: Elucidating the role of AAA ATPase TRIP13 in prostate cancer$222,656
U54 · FY2023 · CA · contact PI
The interplay of social and molecular determinants in lung cancer disparity$589,297
R01 · FY2022 · CA
Project 1: Elucidating the role of AAA ATPase TRIP13 in prostate cancer$222,657
U54 · FY2022 · CA · contact PI
Project 1: Elucidating the role of AAA ATPase TRIP13 in prostate cancer$227,200
U54 · FY2021 · CA · contact PI
Joint Pilot Project #2$106,500
U54 · FY2020 · CA · contact PI
Targeted Nanotherapy for prostate cancer$353,750
SC1 · FY2017 · CA · contact PI
Targeted Nanotherapy for prostate cancer$353,750
SC1 · FY2016 · CA · contact PI
Targeted Nanotherapy for prostate cancer$353,750
SC1 · FY2015 · CA · contact PI
Targeted Nanotherapy for prostate cancer$353,750
SC1 · FY2014 · CA · contact PI